top of page
Group 428 (1).png

Developing a  New Standard of Needle Accuracy

Know whether or not you hit blood when you do an injection.

Anim_Transparent-stop.png
BLURArtboard 2.png
Anchor 1
Group 671.png
INJECT SAFELY
EVERY 24 SECONDS
A PATIENT DIES FROM A NEEDLE STICK*

44 Billion Injections/Year

https://www.ncbi.nlm.nih.gov

DEATH DUE TO
A MISPLACED
INJECTION IS A
"NEVER EVENT"

Acies is designed to provide, real-time indication of the presence or absence of blood in a needle-based procedure.

Group 645.png
Are You Ready to Save Lives?
Anchor 4

We Take Pride in Our Leadership

150

10k

25k

Years Collective Experience

Patients Served

Injections Given

22

Countries World Wide

5

Industry Awards

Never Event Prevention

The National Quality Forum and Centers for Medicare define "Never Events" in health care as "errors in medical care that are clearly identifiable, preventable, and serious in their consequences for patients, and indicate a critical problem in safety and credibility of a health care facility." Events which result in patient death or serious disability have been associated with an intravascular air embolism that occurs while being cared for in a healthcare facility in which a device is used for functions other than its intended purpose.

​

Other forms of inadvertent embolism cause similar harm. Local anesthetics injected into the vasculature can cause cardiac dysrhythmia and death, known as LAST- Local Anesthetic Toxicity Syndrome. Over 300 million dental procedures occur in the United States annually. When local anesthetic infused with epinephrine is introduced into the dental vasculature, preventable deaths may result. We at ACIES believe this fits National Quality Foundation and Medicare guidelines of a Never Event and we offer a solution of prevention.

​

​

Similarly, inadvertent intravascular mRNA vaccine injections, aka vaccine embolism, have a strong link to myocarditis. This article from the Oxford University Press describes the mechanisms in detail: https://www.ncbi.nlm.nih.gov/pmc/arti . France advised against the Moderna Vaccine for citizens Under-30 due to this risk. In a recent survey, only 18% of U.S. parents are willing to administer mRNA vaccine to their young children. The "Never Event" of vaccine embolism, which ACIES is designed to prevent, drives vaccine hesitancy, and is a major public health concern.

Identify a "Never Event" before it ever happens. Get Acies.

​

https://pubmed.ncbi.nlm.nih.gov

Anchor 3
Group 671.png

The Importance of Time

First invented in 1844, over 95% of radiologists agree that needles need to be improved for patient safety. The Acies Smart Needle luminesces on contact with blood, assuring the user of appropriate placement prior to an injection without the use of radiation, kidney damaging contrast dye, or user-dependent ultrasound.

​

There is a saying in the Emergency Room, that “Time is Heart” and “Time is Brain.” Obtaining rapid vascular access for trauma patients, cardiac patients, and stroke patients affects outcomes. In the case of a heart attack, taking longer than 55 minutes to initiate angioplasty, known as Door-to-Balloon-Time, increases the risk of death by 400%. Similarly for stroke, each minute delayed in evacuating a brain clot destroys over 7.5 miles (12.07km) of myelinated fiber in the brain. Patients can not afford delays due to the inability to obtain IV access.

​

From an economic perspective, delays in obtaining IV access create a tremendous cost, not only in terms of more complicated outcomes but also in lost revenue. At Medicare rates, which are a fraction of commercial insurance reimbursement, the opportunity cost of not performing an angioplasty is $ 250/minute at minimum.

COSTS:

DesignElements-02.png
Inadvertent Placement & Time to Access

If there is difficulty accessing two patients in the morning, and two in the afternoon for 10 minutes represents a minimum revenue loss of $10,000 per day, in excess of $2 Million annually, per cardiac catheterization and neurovascular labwork. We believe the value proposition for Acies in this scenario, both driving outcomes and lowering costs, is an ideal target market.

​

Assurance of appropriate placement is critical for central line placement to avoid lung puncture; for chemotherapy to eliminate subcutaneous delivery of caustic chemotherapeutic agents; in infusion therapy of costly immunotherapies as well as for neonatal and pediatric needle sticks.

​

In the Dental market, patients are at risk in the dental chair if the richly vascular gum tissue inadvertently absorbs anesthetics that are then delivered to the heart. While rare, cardiac dysrhythmia or death can occur. Death due to this type of inadvertent intravascular injection is a serious risk and referred to as a “Never Event”.

Frame 573.png

ACIES SMART NEEDLE IS NEEDED FOR MORE
THAN JUST VACCINE APPLICATIONS

Group 634.png
MULTIPLE VERTICAL MARKETS
 
DesignElements-01 (1).png
DesignElements-01 (1).png
Ellipse 12.png

Dr. Daniel Sipple

Founder, Double Board Certified
SBMT Global Think Tank

Ellipse 12 (1).png

Jim Bracke, PhD

Microbiologist
39 Years Medical Science

Ellipse 12 (3).png

Brian L. Norling

CTO, Inventor of Norlinium; owns 60+ Patents; Aerospace Consultant

Anchor 2
Millimeters & Seconds
Drive Safety & Outcomes
Line 20.png

Inadvertent Placement & Time to Access

STRATEGIC PARTNERSHIPS
bottom of page